These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28233242)

  • 1. Ambiguities in the Guidelines for the Management of Arterial Hypertension: Indian Perspective with a Call for Global Harmonization.
    Rehan HS; Grover A; Hungin AP
    Curr Hypertens Rep; 2017 Feb; 19(2):17. PubMed ID: 28233242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension.
    O'Brien E; Staessen JA
    Expert Opin Pharmacother; 2000 May; 1(4):675-82. PubMed ID: 11249509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.
    Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ
    J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients.
    Hoshide S; Kario K; Tomitani N; Kabutoya T; Chia YC; Park S; Shin J; Turana Y; Tay JC; Buranakitjaroen P; Chen CH; Nailes J; Minh HV; Siddique S; Sison J; Soenarta AA; Sogunuru GP; Sukonthasarn A; Teo BW; Verma N; Zhang Y; Wang TD; Wang JG
    J Clin Hypertens (Greenwich); 2020 Mar; 22(3):369-377. PubMed ID: 31891452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension.
    Tocci G; Presta V; Ferri C; Redon J; Volpe M
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):51-59. PubMed ID: 31916207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Bell CM; Mahon JL; Leiter LA; Rabkin SW; Hill MD; Padwal R; Touyz RM; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Moe G; Prasad R; Arnold MO; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; DeChamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Bacon SL; Lindsay P; Gilbert RE; Lewanczuk RZ; Tobe S;
    Can J Cardiol; 2009 May; 25(5):287-98. PubMed ID: 19417859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of elderly hypertension based on various hypertension management guidelines--comparison between European and American guidelines and Japanese guidelines].
    Matsuoka H
    Nihon Rinsho; 2005 Jun; 63(6):945-51. PubMed ID: 15948374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus.
    Katayama S; Inaba M; Morita T; Awata T; Shimamoto K; Kikkawa R
    Hypertens Res; 2000 Nov; 23(6):601-5. PubMed ID: 11131272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
    Circulation; 2018 Oct; 138(17):e595-e616. PubMed ID: 30354656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring.
    Kjeldsen SE; Aksnes TA; Ruilope LM
    Drugs R D; 2014 Jun; 14(2):31-43. PubMed ID: 24842751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.
    Hyman DJ; Pavlik VN
    Arch Intern Med; 2000 Aug 14-28; 160(15):2281-6. PubMed ID: 10927724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH.
    Carter BL
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S18-25. PubMed ID: 15369421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale for differing national recommendations for the treatment of hypertension.
    Ramsay LE; Wallis EJ; Yeo WW; Jackson PR
    Am J Hypertens; 1998 Jun; 11(6 Pt 2):79S-88S; discussion 95S-100S. PubMed ID: 9655567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond JNC 8: implications for evaluation and management of hypertension in underserved populations.
    Burns J; Persaud-Sharma D; Green D
    Acta Cardiol; 2019 Feb; 74(1):1-8. PubMed ID: 29504458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.